스위스 - 독일어 - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - tilidini hydrochloridum - tropfen zum einnehmen - tilidini hydrochloridum 100 mg zu tilidini hydrochloridum hemihydricum sind, saccharinum natricum, conserv.: propylis parahydroxybenzoas natricus, e 219, excipiens zur lösung pro 1 ml endwerte. 40 tropfen, endwerte. ethanolum 19 % v/v. - analgetikum - synthetika

스위스 - 독일어 - Swissmedic (Swiss Agency for Therapeutic Products)

gebro pharma ag - dihydrocodeini hydrochloridum, diphenhydramini hydrochloridum - hustensirup - dihydrocodeini hydrochloridum 10 mg, diphenhydramini hydrochloridum 15 mg, acidum citricum, neohesperidini dihydrochalconum, saccharum 3.9 g, sorbitolum liquidum non cristallisabile 250 mg, aromatica, e 211 3.5 mg, fructuum concentratum, aqua ad solutionem pro 5 ml corresp. natrium 0.55 mg. - husten, reizhusten - synthetika

스위스 - 독일어 - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - ceftriaxonum, lidocaini hydrochloridum anhydricum - pulver und lösungsmittel zur herstellung einer injektionslösung - praeparatio sicca: ceftriaxonum 250 mg ut ceftriaxonum natricum pro vitro corresp. natrium 20.75 mg. solvens: lidocaini hydrochloridum anhydricum 20 mg ut lidocaini hydrochloridum monohydricum, aqua ad iniectabile q.s. ad solutionem pro 2 ml. - infektionskrankheiten - synthetika

스위스 - 독일어 - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - ceftriaxonum, lidocaini hydrochloridum anhydricum - pulver und lösungsmittel zur herstellung einer injektionslösung - praeparatio sicca: ceftriaxonum 1 g ut ceftriaxonum natricum pro vitro corresp. natrium 83 mg. solvens: lidocaini hydrochloridum anhydricum 35 mg ut lidocaini hydrochloridum monohydricum, aqua ad iniectabile q.s. ad solutionem pro 3.5 ml. - infektionskrankheiten - synthetika

스위스 - 독일어 - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - ceftriaxonum, lidocaini hydrochloridum anhydricum - pulver und lösungsmittel zur herstellung einer injektionslösung - praeparatio sicca: ceftriaxonum 500 mg ut ceftriaxonum natricum pro vitro corresp. natrium 41.5 mg. solvens: lidocaini hydrochloridum anhydricum 20 mg ut lidocaini hydrochloridum monohydricum, aqua ad iniectabile q.s. ad solutionem pro 2 ml. - infektionskrankheiten - synthetika

스위스 - 독일어 - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 20 mg, lactosum monohydricum 90 mg, alcohol cetylicus et stearylicus, magnesii stearas, Überzug: Überzug: hypromellosum, macrogolglyceroli hydroxystearas 0.132 mg, talcum, e 171, drucktinte: cera carnauba, lacca, lacca, e 171, e 171, pro compresso obducto. - psychotonikum - synthetika

스위스 - 독일어 - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - methylphenidati hydrochloridum - kapseln - methylphenidati hydrochloridum 20.00 mg, sacchari sphaerae corresp. saccharum max. 112.77 mg et saccharum mg et maydis amylum, maydis amylum, macrogolum 6000, ammonio methacrylatis copolymerum b, acidi methacrylici copolymerum a, talcum, triethylis citras, kapselhülle: gelatina, e 171, drucktinte: drucktinte: lacca, lacca, propylenglycolum, propylenglycolum q.s., kalii hydroxidum, ammoniae solutio 28 per centum, e 171, kalii hydroxidum, e 172 (rubrum), e 171, e 172 (rubrum), e 172 (flavum), e 172 (flavum), pro capsula. - psychotonikum - synthetika

스위스 - 독일어 - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - methylphenidati hydrochloridum - kapseln - methylphenidati hydrochloridum 30 mg, sacchari sphaerae corresp. saccharum max. 169.42 mg et saccharum mg et maydis amylum, maydis amylum, macrogolum 6000, ammonio methacrylatis copolymerum b, acidi methacrylici copolymerum a, talcum, triethylis citras, kapselhülle: gelatina, e 171, e 172 (flavum), drucktinte: drucktinte: lacca, lacca, propylenglycolum, propylenglycolum, ammoniae solutio 28 per centum, kalii hydroxidum, kalii hydroxidum, e 171, e 172 (rubrum), e 171, e 172 (rubrum), e 172 (flavum), e 172 (flavum), pro capsula, pro capsula. - psychotonikum - synthetika

스위스 - 독일어 - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - methylphenidati hydrochloridum - kapseln - methylphenidati hydrochloridum 40 mg, sacchari sphaerae corresp. saccharum mg et saccharum max. 225.89 mg et maydis amylum, maydis amylum, macrogolum 6000, ammonio methacrylatis copolymerum b, acidi methacrylici copolymerum a, talcum, triethylis citras, kapselhülle: gelatina, e 171, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), e 172 (nigrum), e 172 (rubrum), drucktinte: pro capsula, lacca, propylenglycolum, ammoniae solutio 28 per centum, kalii hydroxidum, e 171, e 172 (rubrum), e 172 (flavum), pro capsula. - psychotonikum - synthetika

스위스 - 독일어 - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - methylphenidati hydrochloridum - kapseln - methylphenidati hydrochloridum 10 mg, sacchari sphaerae corresp. saccharum max. 56.48 mg et saccharum mg et maydis amylum, maydis amylum, macrogolum 6000, ammonio methacrylatis copolymerum b, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, talcum, triethylis citras, kapselhülle: gelatina, e 171, e 172 (flavum), e 172 (nigrum), e 172 (rubrum), e 172 (flavum), e 172 (rubrum), e 172 (nigrum), drucktinte: drucktinte: lacca, lacca, propylenglycolum, propylenglycolum, kalii hydroxidum, ammoniae solutio 28 per centum, e 171, kalii hydroxidum, e 171, e 172 (rubrum), e 172 (rubrum), e 172 (flavum), e 172 (flavum), pro capsula, pro capsula. - psychotonikum - synthetika